USD 27.49
(-0.04%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 186.35 Million USD | 21.99% |
2022 | 152.76 Million USD | 23.7% |
2021 | 123.49 Million USD | 27.59% |
2020 | 96.79 Million USD | 28.22% |
2019 | 75.49 Million USD | 67.47% |
2018 | 45.07 Million USD | 63.9% |
2017 | 27.5 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 55.7 Million USD | 8.29% |
2024 Q1 | 51.43 Million USD | 4.6% |
2023 Q2 | 46.61 Million USD | 4.71% |
2023 Q1 | 44.51 Million USD | 6.7% |
2023 FY | 186.35 Million USD | 21.99% |
2023 Q3 | 46.05 Million USD | -1.19% |
2023 Q4 | 49.17 Million USD | 6.77% |
2022 Q4 | 41.72 Million USD | 11.88% |
2022 FY | 152.76 Million USD | 23.7% |
2022 Q1 | 35.39 Million USD | 0.87% |
2022 Q2 | 38.35 Million USD | 8.35% |
2022 Q3 | 37.29 Million USD | -2.77% |
2021 FY | 123.49 Million USD | 27.59% |
2021 Q1 | 26.67 Million USD | -13.69% |
2021 Q4 | 35.09 Million USD | 9.96% |
2021 Q3 | 31.91 Million USD | 7.06% |
2021 Q2 | 29.81 Million USD | 11.74% |
2020 FY | 96.79 Million USD | 28.22% |
2020 Q1 | 22.82 Million USD | 6.55% |
2020 Q4 | 30.9 Million USD | 29.25% |
2020 Q3 | 23.91 Million USD | 24.87% |
2020 Q2 | 19.15 Million USD | -16.09% |
2019 Q4 | 21.42 Million USD | 5.77% |
2019 Q2 | 17.24 Million USD | 4.08% |
2019 Q1 | 16.57 Million USD | 9.74% |
2019 FY | 75.49 Million USD | 67.47% |
2019 Q3 | 20.25 Million USD | 17.4% |
2018 Q3 | 11.41 Million USD | 12.55% |
2018 FY | 45.07 Million USD | 63.9% |
2018 Q1 | 8.41 Million USD | 0.0% |
2018 Q2 | 10.14 Million USD | 20.47% |
2018 Q4 | 15.1 Million USD | 32.3% |
2017 FY | 27.5 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | -1560.344% |
Cerus Corporation | 143.15 Million USD | -30.178% |
OrthoPediatrics Corp. | 137.01 Million USD | -36.008% |
PetVivo Holdings, Inc. | 11.36 Million USD | -1540.342% |
Talis Biomedical Corporation | 67.18 Million USD | -177.375% |
Vivos Therapeutics, Inc. | 24.94 Million USD | -647.042% |
Inogen, Inc. | 236.08 Million USD | 21.064% |
Spectral AI, Inc. | 20.86 Million USD | -793.199% |
Nano-X Imaging Ltd. | 55.99 Million USD | -232.798% |
CVRx, Inc. | 76.14 Million USD | -144.749% |
DIH Holding US, Inc. Warrants | 3.52 Million USD | -5182.234% |
Helius Medical Technologies, Inc. | 12.48 Million USD | -1392.169% |
Orthofix Medical Inc. | 667.42 Million USD | 72.078% |
Venus Concept Inc. | 80.47 Million USD | -131.568% |
Accelerate Diagnostics, Inc. | 56.57 Million USD | -229.381% |
Bioventus Inc. | 409.91 Million USD | 54.538% |
BrainsWay Ltd. | 28.01 Million USD | -565.133% |
Envoy Medical, Inc. | 17.89 Million USD | -941.217% |
electroCore, Inc. | 32.03 Million USD | -481.802% |
IceCure Medical Ltd | 16.87 Million USD | -1004.272% |
Lucid Diagnostics Inc. | 42.43 Million USD | -339.19% |
Monogram Orthopaedics, Inc. | 17.63 Million USD | -956.863% |
MaxCyte, Inc. | 84.84 Million USD | -119.644% |
NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1401.454% |
Nexalin Technology, Inc. | 5.78 Million USD | -3123.413% |
PAVmed Inc | 64.82 Million USD | -187.468% |
Rapid Micro Biosystems, Inc. | 51.07 Million USD | -264.848% |
RxSight, Inc. | 103.85 Million USD | -79.448% |
Sight Sciences, Inc. | 126.44 Million USD | -47.377% |
SI-BONE, Inc. | 156.35 Million USD | -19.191% |
TELA Bio, Inc. | 84.18 Million USD | -121.361% |
TriSalus Life Sciences, Inc. | 70.05 Million USD | -166.011% |
Treace Medical Concepts, Inc. | 203.36 Million USD | 8.363% |
LivaNova PLC | 843.54 Million USD | 77.908% |
908 Devices Inc. | 68.08 Million USD | -173.732% |
Alphatec Holdings, Inc. | 483.59 Million USD | 61.464% |
Nemaura Medical Inc. | 7.13 Million USD | -2510.48% |
NeuroPace, Inc. | 75.29 Million USD | -147.499% |
LENSAR, Inc. | 33.33 Million USD | -459.026% |
Apyx Medical Corporation | 51.01 Million USD | -265.277% |
Cutera, Inc. | 197.72 Million USD | 5.749% |
STRATA Skin Sciences, Inc. | 24.78 Million USD | -652.016% |
BioSig Technologies, Inc. | 28.53 Million USD | -553.197% |
Anika Therapeutics, Inc. | 191.47 Million USD | 2.673% |
ClearPoint Neuro, Inc. | 36.06 Million USD | -416.797% |
Integra LifeSciences Holdings Corporation | 836.39 Million USD | 77.719% |
Axonics, Inc. | 270.2 Million USD | 31.03% |
Outset Medical, Inc. | 198.77 Million USD | 6.245% |
IRIDEX Corporation | 31.81 Million USD | -485.77% |
PROCEPT BioRobotics Corporation | 180.21 Million USD | -3.406% |
IRadimed Corporation | 30.12 Million USD | -518.657% |
Tivic Health Systems, Inc. | 8.53 Million USD | -2084.212% |
INVO Bioscience, Inc. | 7.85 Million USD | -2272.979% |
Telesis Bio, Inc. | 63.48 Million USD | -193.526% |
Viemed Healthcare, Inc. | 98.45 Million USD | -89.285% |
Varex Imaging Corporation | 224.8 Million USD | 17.101% |
Quipt Home Medical Corp. | 148.66 Million USD | -25.352% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1489.67% |
Pulmonx Corporation | 112.68 Million USD | -65.376% |
Dynatronics Corporation | 9.9 Million USD | -1780.869% |
Modular Medical, Inc. | 17.52 Million USD | -963.135% |
ReShape Lifesciences Inc. | 20.18 Million USD | -823.154% |
Semler Scientific, Inc. | 38.94 Million USD | -378.526% |
InMode Ltd. | 215.68 Million USD | 13.596% |
Bruker Corporation | 1.07 Billion USD | 82.687% |
Cytosorbents Corporation | 48.33 Million USD | -285.538% |
DexCom, Inc. | 1.69 Billion USD | 88.981% |
Align Technology, Inc. | 2.07 Billion USD | 91.027% |
Viveve Medical, Inc. | 22.17 Million USD | -740.468% |
ZimVie Inc. | 275.12 Million USD | 32.265% |
Movano Inc. | 29.69 Million USD | -527.676% |
Cytek Biosciences, Inc. | 137.27 Million USD | -35.758% |
Nexalin Technology, Inc. | 5.78 Million USD | -3123.413% |
DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -5182.234% |
Tandem Diabetes Care, Inc. | 600.92 Million USD | 68.988% |
Profound Medical Corp. | 33.6 Million USD | -454.582% |
Insulet Corporation | 939.9 Million USD | 80.173% |
enVVeno Medical Corporation | 25.23 Million USD | -638.398% |
Surmodics, Inc. | 98.69 Million USD | -88.817% |
iCAD, Inc. | 22.22 Million USD | -738.502% |
Nuwellis, Inc. | 22.61 Million USD | -724.114% |
Biotricity, Inc. | 17.18 Million USD | -984.445% |
iRhythm Technologies, Inc. | 445.88 Million USD | 58.206% |
Aethlon Medical, Inc. | 12.27 Million USD | -1417.873% |
InspireMD, Inc. | 22.95 Million USD | -712.013% |
PAVmed Inc. | 64.82 Million USD | -187.468% |
BIOLASE, Inc. | 34.66 Million USD | -437.656% |
Beyond Air, Inc. | 61.7 Million USD | -202.037% |
FONAR Corporation | 28.6 Million USD | -551.491% |
AxoGen, Inc. | 149.33 Million USD | -24.79% |
Vivani Medical, Inc. | 26.96 Million USD | -591.107% |
Tactile Systems Technology, Inc. | 177.09 Million USD | -5.232% |
Inari Medical, Inc. | 448.59 Million USD | 58.458% |
UFP Technologies, Inc. | 58.08 Million USD | -220.813% |
QT Imaging Holdings, Inc. | 4.92 Million USD | -3681.903% |
Heart Test Laboratories, Inc. | 6.31 Million USD | -2849.485% |
Tenon Medical, Inc. | 16.96 Million USD | -998.285% |
Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2420.722% |
Co-Diagnostics, Inc. | 44.1 Million USD | -322.551% |
AdaptHealth Corp. | 1.07 Billion USD | 82.712% |
Sintx Technologies, Inc. | 15.2 Million USD | -1125.952% |
NanoVibronix, Inc. | 4.97 Million USD | -3647.376% |
Quanterix Corporation | 118.1 Million USD | -57.796% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1489.67% |
Sensus Healthcare, Inc. | 14.44 Million USD | -1190.382% |
Pacific Biosciences of California, Inc. | 392.66 Million USD | 52.541% |
TransMedics Group, Inc. | 182.82 Million USD | -1.935% |
ReWalk Robotics Ltd. | 28.06 Million USD | -564.019% |
NeuroMetrix, Inc. | 11.09 Million USD | -1579.053% |
Hyperfine, Inc. | 52.87 Million USD | -252.468% |
Establishment Labs Holdings Inc. | 172 Million USD | -8.345% |
Biomerica, Inc. | 6.97 Million USD | -2570.636% |
Bone Biologics Corporation | 9.42 Million USD | -1876.57% |
AVITA Medical, Inc. | 80.77 Million USD | -130.699% |
Bluejay Diagnostics, Inc. | 10.31 Million USD | -1707.323% |